Avances tecnológicos en apoyo al tratamiento de la ictericia neonatal

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

At the total of the newborns births to 40 to 60% they present levels of hyperbilirrubinemia and in the premature ones this percentage even rises 80%, this state can appear in the first 24 hours of having been born and it is usually due to diverse such problems as sanguine incompatibility, immaturity of its organs, intolerance to the maternal milk. At the present time diverse therapies exist for the normalization of the levels of serum bilirrubin, among them the phototherapy is known like one of those most effective, and for their character non invasive its considered their high-priority one for the handling of these patients, in this work the new existent technologies are presented for the treatment of this pathology that can leave serious consequences in the patients if its not controlled and eliminated on time. Blue light lamp with different elements: fluorescents tube, optic fiber with halogen bulb and blue led with high efficiency are the most used technology actually. © Springer-Verlag Berlin Heidelberg 2007.

Cite

CITATION STYLE

APA

Ferre, A. M. (2008). Avances tecnológicos en apoyo al tratamiento de la ictericia neonatal. In IFMBE Proceedings (Vol. 18, pp. 886–889). Springer Verlag. https://doi.org/10.1007/978-3-540-74471-9_205

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free